PharmaCyte Biotech Overview

PharmaCyte Biotech Operating Income

Operating Income for PMCB.

Quarterly Operating Income

$-2118102.00

↑ 120.58% YoY

As of Jan 31, 2026

Annual Operating Income (TTM)

$-5384322.00

↑ 19.61% YoY

Trailing 12 months ending Jan 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin